Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2014/754693 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558072286937088 |
|---|---|
| author | DE Moulin A Boulanger AJ Clark H Clarke T Dao GA Finley A Furlan I Gilron A Gordon PK Morley-Forster BJ Sessle P Squire J Stinson P Taenzer A Velly MA Ware EL Weinberg OD Williamson |
| author_facet | DE Moulin A Boulanger AJ Clark H Clarke T Dao GA Finley A Furlan I Gilron A Gordon PK Morley-Forster BJ Sessle P Squire J Stinson P Taenzer A Velly MA Ware EL Weinberg OD Williamson |
| author_sort | DE Moulin |
| collection | DOAJ |
| description | BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians. |
| format | Article |
| id | doaj-art-eea3d62cadc4495eb03e121c29af461a |
| institution | Kabale University |
| issn | 1203-6765 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-eea3d62cadc4495eb03e121c29af461a2025-02-03T01:33:27ZengWileyPain Research and Management1203-67652014-01-0119632833510.1155/2014/754693Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain SocietyDE MoulinA BoulangerAJ ClarkH ClarkeT DaoGA FinleyA FurlanI GilronA GordonPK Morley-ForsterBJ SessleP SquireJ StinsonP TaenzerA VellyMA WareEL WeinbergOD WilliamsonBACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians.http://dx.doi.org/10.1155/2014/754693 |
| spellingShingle | DE Moulin A Boulanger AJ Clark H Clarke T Dao GA Finley A Furlan I Gilron A Gordon PK Morley-Forster BJ Sessle P Squire J Stinson P Taenzer A Velly MA Ware EL Weinberg OD Williamson Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society Pain Research and Management |
| title | Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society |
| title_full | Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society |
| title_fullStr | Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society |
| title_full_unstemmed | Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society |
| title_short | Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society |
| title_sort | pharmacological management of chronic neuropathic pain revised consensus statement from the canadian pain society |
| url | http://dx.doi.org/10.1155/2014/754693 |
| work_keys_str_mv | AT demoulin pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT aboulanger pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT ajclark pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT hclarke pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT tdao pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT gafinley pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT afurlan pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT igilron pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT agordon pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT pkmorleyforster pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT bjsessle pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT psquire pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT jstinson pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT ptaenzer pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT avelly pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT maware pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT elweinberg pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety AT odwilliamson pharmacologicalmanagementofchronicneuropathicpainrevisedconsensusstatementfromthecanadianpainsociety |